Order Article Reprints

Zoghbi M, Patel BA, Roulleaux Dugage M, Mezquita L, Bahleda R, Dufresne A, Brahmi M, Ray-Coquard I, Pautier P, Blay J-Y, et al. Association of Lung Immune Prognostic Index (LIPI) with Disease Control Rate and Progression-Free Survival in Patients with Soft-Tissue Sarcoma Treated with Immunotherapy in Early-Phase Trials. Cancers. 2024; 16(23):4053. https://doi.org/10.3390/cancers16234053

Zoghbi, Marianne, Brina A. Patel, Matthieu Roulleaux Dugage, Laura Mezquita, Rastilav Bahleda, Armelle Dufresne, Mehdi Brahmi, Isabelle Ray-Coquard, Patricia Pautier, Jean-Yves Blay, and et al. 2024. "Association of Lung Immune Prognostic Index (LIPI) with Disease Control Rate and Progression-Free Survival in Patients with Soft-Tissue Sarcoma Treated with Immunotherapy in Early-Phase Trials" Cancers 16, no. 23: 4053. https://doi.org/10.3390/cancers16234053

Zoghbi, M., Patel, B. A., Roulleaux Dugage, M., Mezquita, L., Bahleda, R., Dufresne, A., Brahmi, M., Ray-Coquard, I., Pautier, P., Blay, J.-Y., Le Cesne, A., Massard, C., Besse, B., Auclin, E., & Nassif Haddad, E. F. (2024). Association of Lung Immune Prognostic Index (LIPI) with Disease Control Rate and Progression-Free Survival in Patients with Soft-Tissue Sarcoma Treated with Immunotherapy in Early-Phase Trials. Cancers, 16(23), 4053. https://doi.org/10.3390/cancers16234053